1983
DOI: 10.1016/0002-9343(83)90141-9
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
32
0
1

Year Published

1987
1987
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 99 publications
(33 citation statements)
references
References 19 publications
0
32
0
1
Order By: Relevance
“…Therefore, also thanks to an effect of coronary arteries dilatation, it is recommended for patients affected by hypertension associated with acute coronary insuficiency and it is not recommended for use in volume-depleted patients, or in those in whom cardiac output is preload dependent. It is also very useful in case of acute pulmonary oedema, but, in other conditions it is not recommended as a single primary blood pressure control agent due to its unpredictability to reduce blood pressure, the induction of a reflex tachycardia exacerbated by volume depletion, the early onset of tachyphylaxis (about 4 hours) and the formation of methemoglobinaemia after a prolonged use [6,16]. …”
Section: Nitroglycerinmentioning
confidence: 99%
“…Therefore, also thanks to an effect of coronary arteries dilatation, it is recommended for patients affected by hypertension associated with acute coronary insuficiency and it is not recommended for use in volume-depleted patients, or in those in whom cardiac output is preload dependent. It is also very useful in case of acute pulmonary oedema, but, in other conditions it is not recommended as a single primary blood pressure control agent due to its unpredictability to reduce blood pressure, the induction of a reflex tachycardia exacerbated by volume depletion, the early onset of tachyphylaxis (about 4 hours) and the formation of methemoglobinaemia after a prolonged use [6,16]. …”
Section: Nitroglycerinmentioning
confidence: 99%
“…Labetalol has been evaluated for use in both hypertensive emergencies and urgencies with intravenous (64)(65)(66)(67) and oral (61,62,(68)(69)(70) preparations, respectively. Trials investigating intravenous labetalol have studied various dosage regimens which include: (I) a bolus dose followed by a continuous infusion (60); (2) a constant infusion without a bolus dose (66,71); (3) a single large bolus dose (71); and (4) repeated bolus injections (64,65,71,72).…”
Section: Direct Vasodilatorsmentioning
confidence: 99%
“…Trials investigating intravenous labetalol have studied various dosage regimens which include: (I) a bolus dose followed by a continuous infusion (60); (2) a constant infusion without a bolus dose (66,71); (3) a single large bolus dose (71); and (4) repeated bolus injections (64,65,71,72). Overall, each of the regimens provides effective BP control.…”
Section: Direct Vasodilatorsmentioning
confidence: 99%
See 2 more Smart Citations